+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluorouracil"

From
From
From
Liver Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 239 Pages
  • China
From
Liver Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Companies in China

  • Report
  • September 2024
  • 69 Pages
  • China
From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 199 Pages
  • China
From
From
From
Loading Indicator

Fluorouracil (5-FU) is a chemotherapy drug used in the treatment of cancer. It is a pyrimidine analog, which interferes with the synthesis of DNA and RNA, leading to cell death. It is used to treat a variety of cancers, including breast, colorectal, gastric, pancreatic, and head and neck cancers. It is also used in combination with other drugs to treat advanced or metastatic cancers. Fluorouracil is administered intravenously or topically, depending on the type of cancer being treated. Fluorouracil is a widely used drug in the oncology market, and is often used in combination with other drugs to treat advanced or metastatic cancers. It is a generic drug, and is available in both branded and generic formulations. The branded formulations are typically more expensive than the generic versions. Companies in the Fluorouracil market include Pfizer, Merck, Bristol-Myers Squibb, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more